Inflammatory Factors in Allergic Rhinitis: A 20‐Year Bibliometric Mapping and Emerging Trends
Flavour and Fragrance Journal, Volume 41, Issue 5, Page 1076-1089, September 2026.This figure illustrates the bibliometric process and results of research on inflammatory factors of allergic rhinitis from 2004 to 2024 including data screening, global distribution, collaborative networks and the evolution of research hotspots. ABSTRACT Allergic rhinitis (AR) is driven by a network of inflammatory mediators released by mast cells ...
Shanshan Jing, Fengying Zhang, Qiqi Liu
wiley +1 more source
The Use of Biological Therapies in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Current State of Knowledge. [PDF]
J Clin MedWrona J +6 more
europepmc +1 more source
Health Science Reports, Volume 9, Issue 9, September 2026.ABSTRACT Background and Aims Epistaxis is a common complication associated with oral anticoagulant and antiplatelet therapies, often leading to significant morbidity. In recent years, the incidence of cardiovascular disease in Nepal has risen dramatically, driving a widespread use of these medications and heightened concerns regarding bleeding ...
Shiv Kumar Sah +9 more
wiley +1 more source
Advance in biologics for chronic rhinosinusitis with nasal polyps. [PDF]
Front AllergyDi Y, Zeng R, Huang L, Wu Y, Wu Q.
europepmc +1 more source
Lateral Mucosal Flap With Steroid‐Eluting Implant in Revision Draf Type III Frontal Sinus Surgery
The Laryngoscope, Volume 136, Issue 9, Page 3732-3736, September 2026.This technical note introduces a novel endoscopic strategy that integrates a laterally based endonasal mucosal flap with a bioabsorbable steroid‐eluting implant to prevent restenosis following revision of Draf type III frontal sinus surgery. The vascularized flap is stabilized and maintained in close apposition to the underlying bone by a self ...
Mario Turri‐Zanoni +6 more
wiley +1 more source
Galectin-10 and Charcot-Leyden Crystals in Chronic Rhinosinusitis with Nasal Polyps: Pathogenetic Insights and Clinical Implications. [PDF]
Diagnostics (Basel)Kamiński B +4 more
europepmc +1 more source
Unique Features of Nasal Airway and Airflow Improvement Post‐Dupilumab: A Computational Cohort Study
The Laryngoscope, Volume 136, Issue 9, Page 3744-3751, September 2026.The impact of dupilumab on nasal airway patency and airflow is not uniform. It is more pronounced in the middle and superior, but not inferior meatus. These unique regional changes significantly correlate with and potentially drive the improvement in patient symptoms.
Ahmad Odeh +12 more
wiley +1 more source
Comment on "Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)". [PDF]
Int Forum Allergy RhinolMalik MMUD.
europepmc +1 more source
Neighborhood Deprivation and Voice and Reflux Symptom Burden in a Tertiary Laryngology Cohort
The Laryngoscope, Volume 136, Issue 9, Page 3826-3840, September 2026.ABSTRACT Objective The voice handicap index‐10 (VHI‐10) and reflux symptoms index (RSI) are validated, patient‐reported outcome measures (PROMs) commonly used in laryngology to assess the subjective impact of voice disorders and severity of symptoms associated with laryngopharyngeal reflux, respectively.
Sandra Stinnett +6 more
wiley +1 more source
Economic evaluation of stapokibart for chronic rhinosinusitis with nasal polyps in China: a cost-effectiveness analysis. [PDF]
J Comp Eff ResYang J, Ren L, Xie F, Shao R, Jiang R.
europepmc +1 more source